C-terminal anthranoyl-anthranilic acid derivatives and their evaluation on CCK receptors

Farmaco

Volumn 55, Issue 4, 2000, Pages 293-302

  Varnavas, Antonio ^a   Lassiani, Lucia ^a   Luxich, Elena ^a   Valenta, Valentina ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Anthranilic acid dimer; CCK ligands

Indexed keywords

ANTHRANILIC ACID DERIVATIVE; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR STIMULATING AGENT;

ANIMAL TISSUE; ARTICLE; BINDING KINETICS; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GUINEA PIG; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTHRANILIC ACIDS; GUINEA PIGS; LIGANDS; MOLECULAR STRUCTURE; RATS; RECEPTOR, CHOLECYSTOKININ A; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ;

EID: 0033846302     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(00)00043-4     Document Type: Article

References (22)

1. Williams J.A. Biomed. Res. 3:1982;107-121.
2. Crawley J.N., Corwin R.L. Peptides. 15:1994;731-755.
3. Innis R.B., Snyder S.H. Proc. Natl. Acad. Sci. USA. 77:1980;6917-6921.
4. Dourish C.T., Hill D.R. Trends Pharmacol. Sci. 8:1987;207-208.
5. D'Amato M., Makovec F., Rovati L.C. Drug News Perspect. 7:1994;87-95.
6. Hill D.R., Singh L., Boden P., Pinnock R., Woodruff G.N., Hughes J. Dourish C.T., Cooper S.J., Iversen S.D., Iversen L.L. Multiple Cholecystokinin Receptors in the CNS. 1992;57-76 Oxford University Press, London.
7. Rex A., Marsden C.A., Fink H. Neurosci. Lett. 228:1997;79-82.
8. Ballaz S., Barber A., Fortuno A., Del Rio J., Martin-Martinez M., Gomez-Monterrey I., Herranz R., Gonzalez-Muniz R., Garcia-Lopez M.T. Br. J. Pharmacol. 121:1997;759-767.
9. Singh L., Oles R.J., Field M.J., Atwal P., Woodruff G.N., Hunter J.C. Br. J. Pharmacol. 118:1996;1317-1325.
10. Urban M.O., Smith D.J., Gebhart G.F. J. Pharmacol. Exp. Ther. 278:1996;90-96.
11. Makovec F. Drugs Future. 18:1993;919-931.
12. Makovec F., Peris W., Frigerio S., Giovanetti R., Letari O., Mennuni L., Revel L. J. Med. Chem. 39:1996;135-142.
13. Evans B.E., Bock M.G., Rittle K.E., Di Pardo R.M., Whitter W.L., Veber D.F., Anderson P.S., Freidinger R.M. Proc. Natl. Acad. Sci. USA. 83:1986;4918-4922.
14. Bock M.G., Di Pardo R.M., Evans B.E., Rittle K.E., Whitter W.L., Veber D.F., Anderson P.S., Freidinger R.M. J. Med. Chem. 32:1989;13-16.
15. Yu M.J., Trasher K.J., McCowan J.R., Mason N.R., Mendelson L.G. J. Med. Chem. 34:1991;1505-1508.
16. Boden P.R., Higginbottom M., Hill D.R., Horwell D.C., Hughes J., Rees D.C., Roberts E., Singh L., Suman-Chauhan N., Woodruff G.N. J. Med. Chem. 36:1993;552-565.
17. Drysdale M.J., Pritchard M.C., Horwell D.C. J. Med. Chem. 35:1992;2573-2581.
18. Varnavas A., Lassiani L., Luxich E., Zacchigna M. Pharmazie. 51:1996;697-700.
19. Chang R.S.L., Lotti V.J., Chen T.B., Kunkel K.A. Mol. Pharmacol. 30:1986;212-217.
20. Chang R.S.L., Chen T.B., Bock M.G., Freidinger R.M., Chen R., Rosegay A., Lotti V.J. Mol. Pharmacol. 35:1989;803-808.
21. Bock M.G., Di Pardo R.M., Rittle K.E., Evans B.E., Freidinger R.M., Veber D.F., Chang R.S.L., Chen T.B., Keegan M.E., Lotti V.J. J. Med. Chem. 29:1986;1941-1945.
22. Bock M.G., Di Pardo R.M., Evans B.E., Rittle K.E., Veber D.F., Freidinger R.M., Hirshfield J., Springer J.P. J. Org. Chem. 52:1987;3232-3239.